Free Trial

Leerink Partnrs Brokers Lower Earnings Estimates for UNH

UnitedHealth Group logo with Medical background

UnitedHealth Group Incorporated (NYSE:UNH - Free Report) - Stock analysts at Leerink Partnrs cut their Q2 2025 earnings per share (EPS) estimates for shares of UnitedHealth Group in a report released on Tuesday, July 15th. Leerink Partnrs analyst W. Mayo now expects that the healthcare conglomerate will post earnings per share of $3.69 for the quarter, down from their prior forecast of $5.24. The consensus estimate for UnitedHealth Group's current full-year earnings is $29.54 per share. Leerink Partnrs also issued estimates for UnitedHealth Group's Q3 2025 earnings at $3.60 EPS, Q4 2025 earnings at $3.69 EPS, FY2025 earnings at $18.20 EPS, Q1 2026 earnings at $6.25 EPS, Q2 2026 earnings at $5.08 EPS, Q3 2026 earnings at $4.93 EPS, Q4 2026 earnings at $4.73 EPS, FY2026 earnings at $21.00 EPS, FY2027 earnings at $26.24 EPS, FY2028 earnings at $30.07 EPS and FY2029 earnings at $33.34 EPS.

UNH has been the topic of a number of other reports. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. Finally, UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $394.43.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Down 2.0%

UNH stock traded down $5.62 during trading on Thursday, reaching $282.45. 14,902,160 shares of the stock were exchanged, compared to its average volume of 7,804,386. The business has a 50 day moving average price of $304.47 and a 200-day moving average price of $433.39. The firm has a market capitalization of $256.22 billion, a price-to-earnings ratio of 11.83, a P/E/G ratio of 1.41 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter last year, the firm earned $6.91 earnings per share.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.13%. The ex-dividend date was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the stock in a transaction dated Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the purchase, the chief financial officer owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.28% of the stock is owned by corporate insiders.

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the fourth quarter valued at $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $28,000. Bayforest Capital Ltd boosted its stake in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines